688161 威高骨科
已收盘 01-09 15:00:01
资讯
新帖
简况
每周股票复盘：威高骨科（688161）拟变更募投项目收购杰思拜尔
证券之星 · 01-02
每周股票复盘：威高骨科（688161）拟变更募投项目收购杰思拜尔
威高骨科（688161）披露变更部分募投项目并收购苏州杰思拜尔股权，12月29日股价下跌0.49%
证券之星 · 2025-12-29
威高骨科（688161）披露变更部分募投项目并收购苏州杰思拜尔股权，12月29日股价下跌0.49%
威高骨科（688161）披露拟变更部分募投项目用于收购杰思拜尔55%股权，12月22日股价下跌0.18%
证券之星 · 2025-12-22
威高骨科（688161）披露拟变更部分募投项目用于收购杰思拜尔55%股权，12月22日股价下跌0.18%
威高骨科（688161）披露设立募集资金专项账户议案，12月17日股价上涨0.91%
证券之星 · 2025-12-17
威高骨科（688161）披露设立募集资金专项账户议案，12月17日股价上涨0.91%
威高骨科（688161）披露拟变更部分募投项目并收购杰思拜尔股权，12月11日股价下跌1.06%
证券之星 · 2025-12-11
威高骨科（688161）披露拟变更部分募投项目并收购杰思拜尔股权，12月11日股价下跌1.06%
每周股票复盘：威高骨科（688161）董事总经理工作调整
证券之星 · 2025-11-23
每周股票复盘：威高骨科（688161）董事总经理工作调整
威高骨科总经理变动
赛柏蓝器械 · 2025-11-20
威高骨科总经理变动
威高骨科（688161）披露公司董事、总经理工作调整，11月19日股价下跌2.44%
证券之星 · 2025-11-19
威高骨科（688161）披露公司董事、总经理工作调整，11月19日股价下跌2.44%
因工作调整原因，威高骨科董事、总经理卢均强辞职
北京商报 · 2025-11-19
因工作调整原因，威高骨科董事、总经理卢均强辞职
威高骨科（688161）披露拟聘请会计师事务所议案获股东会通过，11月18日股价下跌0.2%
证券之星 · 2025-11-18
威高骨科（688161）披露拟聘请会计师事务所议案获股东会通过，11月18日股价下跌0.2%
每周股票复盘：威高骨科（688161）Q3净利下降8.03%
证券之星 · 2025-11-02
每周股票复盘：威高骨科（688161）Q3净利下降8.03%
威高骨科（688161）2025年三季报简析：营收净利润同比双双增长，应收账款上升
证券之星 · 2025-11-01
威高骨科（688161）2025年三季报简析：营收净利润同比双双增长，应收账款上升
威高骨科（688161）披露拟聘请会计师事务所议案，10月31日股价上涨0.85%
证券之星 · 2025-10-31
威高骨科（688161）披露拟聘请会计师事务所议案，10月31日股价上涨0.85%
股市必读：威高骨科三季报 - 第三季度单季净利润同比下降8.03%
中金财经 · 2025-10-31
股市必读：威高骨科三季报 - 第三季度单季净利润同比下降8.03%
威高骨科(688161)9月30日股东户数1.07万户，较上期增加18.33%
证券之星 · 2025-10-30
威高骨科(688161)9月30日股东户数1.07万户，较上期增加18.33%
威高骨科第三季度归母净利润同比降8%至6545万元
财中社 · 2025-10-30
威高骨科第三季度归母净利润同比降8%至6545万元
每周股票复盘：威高骨科（688161）每股派现0.10元（含税）
证券之星 · 2025-10-19
每周股票复盘：威高骨科（688161）每股派现0.10元（含税）
威高骨科（688161）披露2025年半年度权益分派实施公告，10月13日股价下跌2.74%
证券之星 · 2025-10-13
威高骨科（688161）披露2025年半年度权益分派实施公告，10月13日股价下跌2.74%
每周股票复盘：威高骨科（688161）拟取消监事会并修订章程
证券之星 · 2025-09-07
每周股票复盘：威高骨科（688161）拟取消监事会并修订章程
每周股票复盘：威高骨科（688161）Q2净利增54.86%
证券之星 · 2025-08-31
每周股票复盘：威高骨科（688161）Q2净利增54.86%
加载更多
公司概况
公司名称：
山东威高骨科材料股份有限公司
所属行业：
专用设备制造业
上市日期：
2021-06-30
主营业务：
山东威高骨科材料股份有限公司的主营业务是骨科医疗器械的研发,生产和销售。公司的主要产品是骨修复材料、组织修复以及骨科手术器械等。
发行价格：
36.22
{"stockData":{"symbol":"688161","market":"SH","secType":"STK","nameCN":"威高骨科","latestPrice":30.13,"timestamp":1767942001000,"preClose":29.89,"halted":0,"volume":1489408,"delay":0,"changeRate":0.008,"floatShares":400000000,"shares":400000000,"eps":0.6672,"marketStatus":"已收盘","change":0.24,"latestTime":"01-09 15:00:01","open":29.79,"high":30.33,"low":29.75,"amount":44806400,"amplitude":0.0194,"askPrice":30.15,"askSize":38,"bidPrice":30.13,"bidSize":51,"shortable":0,"etf":0,"ttmEps":0.6672,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1768181400000},"marketStatusCode":5,"adr":0,"adjPreClose":29.89,"symbolType":"stock_kcb","openAndCloseTimeList":[[1767922200000,1767929400000],[1767934800000,1767942000000]],"highLimit":32.88,"lowLimit":26.9,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":400000000,"isCdr":false,"pbRate":2.96,"roa":"--","peRate":45.158873,"roe":"5.19%","epsLYR":0.56,"committee":-0.536,"marketValue":12052000000,"turnoverRate":0.0037,"status":0,"afterMarket":{"amount":0,"volume":0,"close":30.13,"buyVolume":300,"sellVolume":0,"time":1767944037558,"indexStatus":"已收盘 01-09 15:30:00","preClose":29.89},"floatMarketCap":12052000000},"requestUrl":"/m/hq/s/688161","defaultTab":"news","newsList":[{"id":"2600396130","title":"每周股票复盘：威高骨科（688161）拟变更募投项目收购杰思拜尔","url":"https://stock-news.laohu8.com/highlight/detail?id=2600396130","media":"证券之星","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600396130?lang=zh_cn&edition=full","pubTime":"2026-01-02 04:00","pubTimestamp":1767297639,"startTime":"0","endTime":"0","summary":"截至2025年12月26日收盘，威高骨科报收于28.31元，较上周的28.15元上涨0.57%。本周关注点公司公告汇总：威高骨科拟变更部分募投项目用于收购苏州杰思拜尔股权并对其增资。公司公告汇总山东威高骨科材料股份有限公司于2025年12月29日召开2025年第三次临时股东会，审议通过《关于变更部分募投项目暨收购苏州杰思拜尔医疗科技有限公司股权并对其增资的议案》及增补李进取先生为第三届董事会非独立董事的议案。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010200001177.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688161","BK0251"],"gpt_icon":0},{"id":"2595736979","title":"威高骨科（688161）披露变更部分募投项目并收购苏州杰思拜尔股权，12月29日股价下跌0.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2595736979","media":"证券之星","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595736979?lang=zh_cn&edition=full","pubTime":"2025-12-29 22:52","pubTimestamp":1767019938,"startTime":"0","endTime":"0","summary":"截至2025年12月29日收盘，威高骨科报收于28.17元，较前一交易日下跌0.49%，最新总市值为112.68亿元。该股当日开盘28.2元，最高28.38元，最低28.15元，成交额达1915.11万元，换手率为0.17%。公司近日发布公告称，于2025年12月29日召开2025年第三次临时股东会，审议通过《关于变更部分募投项目暨收购苏州杰思拜尔医疗科技有限公司股权并对其增资的议案》。会议由董事会召集，采用现场与网络投票相结合的方式进行，出席会议的股东共53名，代表有表决权股份总数的83.9587%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122900038364.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688161"],"gpt_icon":0},{"id":"2593485246","title":"威高骨科（688161）披露拟变更部分募投项目用于收购杰思拜尔55%股权，12月22日股价下跌0.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593485246","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593485246?lang=zh_cn&edition=full","pubTime":"2025-12-22 17:53","pubTimestamp":1766397191,"startTime":"0","endTime":"0","summary":"截至2025年12月22日收盘，威高骨科报收于28.1元，较前一交易日下跌0.18%，最新总市值为112.4亿元。该股当日开盘28.2元，最高28.27元，最低27.74元，成交额达4193.28万元，换手率为0.37%。近日，威高骨科发布2025年第三次临时股东会会议资料，其中披露一项重要议案：公司拟变更‘研发中心建设项目’中8,646万元未使用募集资金，用于收购苏州杰思拜尔医疗科技有限公司55%股权并对其增资，交易对价合计8,646万元。本次交易不构成关联交易或重大资产重组。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122200022652.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688161","BK0251"],"gpt_icon":0},{"id":"2592161449","title":"威高骨科（688161）披露设立募集资金专项账户议案，12月17日股价上涨0.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592161449","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592161449?lang=zh_cn&edition=full","pubTime":"2025-12-17 22:45","pubTimestamp":1765982711,"startTime":"0","endTime":"0","summary":"截至2025年12月17日收盘，威高骨科报收于27.74元，较前一交易日上涨0.91%，最新总市值为110.96亿元。该股当日开盘27.31元，最高27.77元，最低27.21元，成交额达2373.54万元，换手率为0.22%。公司近日发布公告称，山东威高骨科材料股份有限公司于2025年12月17日召开第三届董事会第十八次会议，审议通过《关于设立募集资金专项账户并签订募集资金三方监管协议的议案》。表决结果为8票同意，0票反对，0票弃权。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121700040426.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688161","BK0251"],"gpt_icon":0},{"id":"2590151422","title":"威高骨科（688161）披露拟变更部分募投项目并收购杰思拜尔股权，12月11日股价下跌1.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590151422","media":"证券之星","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590151422?lang=zh_cn&edition=full","pubTime":"2025-12-11 22:36","pubTimestamp":1765463782,"startTime":"0","endTime":"0","summary":"截至2025年12月11日收盘，威高骨科报收于28.08元，较前一交易日下跌1.06%，最新总市值为112.32亿元。近日，威高骨科发布关于召开公司2025年第三次临时股东会的通知公告。公告显示，山东威高骨科材料股份有限公司将于2025年12月29日召开2025年第三次临时股东会，会议采取现场投票与网络投票相结合的方式，网络投票通过上海证券交易所系统进行。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121100042371.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688161"],"gpt_icon":0},{"id":"2585066681","title":"每周股票复盘：威高骨科（688161）董事总经理工作调整","url":"https://stock-news.laohu8.com/highlight/detail?id=2585066681","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585066681?lang=zh_cn&edition=full","pubTime":"2025-11-23 04:40","pubTimestamp":1763844020,"startTime":"0","endTime":"0","summary":"截至2025年11月21日收盘，威高骨科报收于28.47元，较上周的31.07元下跌8.37%。本周，威高骨科11月17日盘中最高价报31.18元。议案获得普通股股东同意票336,427,688股，反对37,373股，弃权0股。山东威高骨科材料股份有限公司于2025年11月19日收到董事、总经理卢均强先生的书面辞职申请，因工作调整原因，卢均强先生不再担任公司第三届董事会董事、总经理职务，辞职报告自送达董事会之日起生效。公司后续将按程序开展董事选举和总经理选聘工作。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112300001362.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688161"],"gpt_icon":0},{"id":"2584314131","title":"威高骨科总经理变动","url":"https://stock-news.laohu8.com/highlight/detail?id=2584314131","media":"赛柏蓝器械","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584314131?lang=zh_cn&edition=full","pubTime":"2025-11-20 19:20","pubTimestamp":1763637600,"startTime":"0","endTime":"0","summary":"01威高骨科高管变动11月20日，威高骨科发布公告称，公司董事会于11月19日收到公司董事、总经理卢均强先生递交的书面辞职申请。2018年加入威高骨科，任职销售副总经理，2019年9月接替弓剑波担任威高骨科总经理。2023年10月起担任威高骨科副总经理。作为国产骨科领域的头部企业，威高骨科的业绩走势正是骨科市场变革的缩影。威高骨科还积极推进销售模式的转型。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-11-20/doc-infxzzsw2143624.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0251","688161"],"gpt_icon":0},{"id":"2584947120","title":"威高骨科（688161）披露公司董事、总经理工作调整，11月19日股价下跌2.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584947120","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584947120?lang=zh_cn&edition=full","pubTime":"2025-11-19 22:35","pubTimestamp":1763562921,"startTime":"0","endTime":"0","summary":"截至2025年11月19日收盘，威高骨科报收于29.65元，较前一交易日下跌2.44%，最新总市值为118.6亿元。近日，山东威高骨科材料股份有限公司发布公告称，公司于2025年11月19日收到董事、总经理卢均强先生的书面辞职申请，因工作调整原因，卢均强先生不再担任公司第三届董事会董事、总经理职务，辞职报告自送达董事会之日起生效。公司持股0.10%的股东卢均强先生辞去职务后，将遵守相关股份管理规定。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111900040247.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688161","BK0251"],"gpt_icon":0},{"id":"2584694539","title":"因工作调整原因，威高骨科董事、总经理卢均强辞职","url":"https://stock-news.laohu8.com/highlight/detail?id=2584694539","media":"北京商报","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584694539?lang=zh_cn&edition=full","pubTime":"2025-11-19 18:43","pubTimestamp":1763548980,"startTime":"0","endTime":"0","summary":"北京商报讯（记者丁宁）11月19日晚间，威高骨科（688161）发布公告称，公司董事会于11 月19日收到公司董事、总经理卢均强递交的书面辞职申请。因工作调整原因，卢均强不再担任公司第三届董事会董事、总经理职务，由副总经理李进取代行总经理职责，直至董事会选聘新任总经理。卢均强将继续在公司控股股东、实际控制人控制的企业内任职。（文章来源：北京商报）\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2025-11-19/doc-infxxwtt3486963.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-11-19/doc-infxxwtt3486963.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0251","688161"],"gpt_icon":0},{"id":"2584933068","title":"威高骨科（688161）披露拟聘请会计师事务所议案获股东会通过，11月18日股价下跌0.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584933068","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584933068?lang=zh_cn&edition=full","pubTime":"2025-11-18 18:04","pubTimestamp":1763460270,"startTime":"0","endTime":"0","summary":"截至2025年11月18日收盘，威高骨科报收于30.39元，较前一交易日下跌0.2%，最新总市值为121.56亿元。该股当日开盘30.38元，最高30.65元，最低29.99元，成交额达3898.4万元，换手率为0.32%。公司于近日发布公告称，山东威高骨科材料股份有限公司于2025年11月17日召开2025年第二次临时股东会，审议通过《关于公司拟聘请会计师事务所的议案》。议案获得普通股股东同意票336,427,688股，反对37,373股，弃权0股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111800028395.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688161","BK0251"],"gpt_icon":0},{"id":"2580405780","title":"每周股票复盘：威高骨科（688161）Q3净利下降8.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580405780","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580405780?lang=zh_cn&edition=full","pubTime":"2025-11-02 10:34","pubTimestamp":1762050851,"startTime":"0","endTime":"0","summary":"截至2025年10月31日收盘，威高骨科报收于29.72元，较上周的30.33元下跌2.01%。本周，威高骨科10月27日盘中最高价报30.88元。公司公告汇总：威高骨科将于2025年11月17日召开第二次临时股东会。股本股东变化截至2025年9月30日，威高骨科股东户数为1.07万户，较6月30日增加1656.0户，增幅18.33%。业绩披露要点威高骨科2025年三季报显示，前三季度主营收入11.06亿元，同比增长2.12%；归母净利润2.07亿元，同比增长26.24%；扣非净利润1.94亿元，同比增长22.06%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110200002414.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688161","BK0251"],"gpt_icon":0},{"id":"2580417309","title":"威高骨科（688161）2025年三季报简析：营收净利润同比双双增长，应收账款上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2580417309","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580417309?lang=zh_cn&edition=full","pubTime":"2025-11-01 06:48","pubTimestamp":1761950894,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期威高骨科发布2025年三季报。截至本报告期末，公司营业总收入11.06亿元，同比上升2.12%，归母净利润2.07亿元，同比上升26.24%。本报告期威高骨科应收账款上升，应收账款同比增幅达34.34%。去年的净利率为15.71%，算上全部成本后，公司产品或服务的附加值高。财报体检工具显示：建议关注公司应收账款状况分析师工具显示：证券研究员普遍预期2025年业绩在3.04亿元，每股收益均值在0.76元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110100007815.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688161"],"gpt_icon":0},{"id":"2579645044","title":"威高骨科（688161）披露拟聘请会计师事务所议案，10月31日股价上涨0.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579645044","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579645044?lang=zh_cn&edition=full","pubTime":"2025-10-31 18:34","pubTimestamp":1761906875,"startTime":"0","endTime":"0","summary":"截至2025年10月31日收盘，威高骨科报收于29.72元，较前一交易日上涨0.85%，最新总市值为118.88亿元。该股当日开盘29.1元，最高29.87元，最低29.01元，成交额达6493.53万元，换手率为0.55%。同日，威高骨科发布公告称，公司将于近日召开2025年第二次临时股东会，会议将审议《关于公司拟聘请会计师事务所的议案》。本次会议采取现场投票与网络投票相结合的方式进行，股权登记日为2025年11月10日，A股股东可参会。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103100040100.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688161","BK0251"],"gpt_icon":0},{"id":"2579486864","title":"股市必读：威高骨科三季报 - 第三季度单季净利润同比下降8.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579486864","media":"中金财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579486864?lang=zh_cn&edition=full","pubTime":"2025-10-31 09:22","pubTimestamp":1761873746,"startTime":"0","endTime":"0","summary":"股东户数变动截至2025年9月30日，公司股东户数为1.07万户，较6月30日增加1656.0户，增幅18.33%；户均持股数量由上期的4.43万股下降至3.74万股，户均持股市值为123.11万元。财务报告2025年前三季度，公司实现主营收入11.06亿元，同比增长2.12%；归母净利润2.07亿元，同比增长26.24%；扣非净利润1.94亿元，同比增长22.06%。2025年第三季度单季度主营收入3.65亿元，同比增长9.8%；单季度归母净利润6544.87万元，同比下降8.03%；单季度扣非净利润5864.8万元，同比下降16.17%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20251031/31754699.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["688161"],"gpt_icon":0},{"id":"2579118681","title":"威高骨科(688161)9月30日股东户数1.07万户，较上期增加18.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579118681","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579118681?lang=zh_cn&edition=full","pubTime":"2025-10-30 17:28","pubTimestamp":1761816490,"startTime":"0","endTime":"0","summary":"证券之星消息，近日威高骨科披露，截至2025年9月30日公司股东户数为1.07万户，较6月30日增加1656.0户，增幅为18.33%。在医疗器械行业个股中，威高骨科股东户数低于行业平均水平，截至9月30日，医疗器械行业平均股东户数为2.21万户。从股价来看，2025年6月30日至2025年9月30日，威高骨科区间涨幅为22.81%，在此期间股东户数增加1656.0户，增幅为18.33%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103000033112.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688161"],"gpt_icon":0},{"id":"2579115308","title":"威高骨科第三季度归母净利润同比降8%至6545万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2579115308","media":"财中社","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579115308?lang=zh_cn&edition=full","pubTime":"2025-10-30 17:19","pubTimestamp":1761815940,"startTime":"0","endTime":"0","summary":"10月30日，威高骨科公布2025年三季报，公司营业收入为11.1亿元，同比上升2.1%；归母净利润为2.07亿元，同比上升26.2%；扣非归母净利润为1.94亿元，同比上升22.1%；经营现金流净额为2.5亿元，同比增长31.9%；EPS为0.5185元。其中第三季度，公司营业收入为3.65亿元，同比上升9.8%；归母净利润为6545万元，同比下降8.0%；扣非归母净利润为5865万元，同比下降16.2%；EPS为0.1636元。截至三季度末，公司总资产50.93亿元，较上年度末增长2.9%；归母净资产为40.73亿元，较上年度末增长3.0%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-10-30/doc-infvskck9317515.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["688161"],"gpt_icon":0},{"id":"2576494260","title":"每周股票复盘：威高骨科（688161）每股派现0.10元（含税）","url":"https://stock-news.laohu8.com/highlight/detail?id=2576494260","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576494260?lang=zh_cn&edition=full","pubTime":"2025-10-19 03:49","pubTimestamp":1760816948,"startTime":"0","endTime":"0","summary":"截至2025年10月17日收盘，威高骨科报收于29.32元，较上周的32.12元下跌8.72%。本周，威高骨科10月14日盘中最高价报31.83元。威高骨科当前最新总市值117.28亿元，在医疗器械板块市值排名28/126，在两市A股市值排名1580/5158。本周关注点公司公告汇总：威高骨科2025年半年度每股现金红利0.10元（含税），股权登记日为2025年10月20日。本次分红以总股本400,000,000股扣减回购股份后397,286,124股为基数，派发现金红利总额39,728,612.40元，每股现金红利0.10元（含税）。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101900000785.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688161"],"gpt_icon":0},{"id":"2575040093","title":"威高骨科（688161）披露2025年半年度权益分派实施公告，10月13日股价下跌2.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2575040093","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575040093?lang=zh_cn&edition=full","pubTime":"2025-10-13 22:39","pubTimestamp":1760366363,"startTime":"0","endTime":"0","summary":"截至2025年10月13日收盘，威高骨科报收于31.24元，较前一交易日下跌2.74%，最新总市值为124.96亿元。近日，山东威高骨科材料股份有限公司发布2025年半年度权益分派实施公告。根据公告，本次权益分派每股现金红利0.10元（含税），股权登记日为2025年10月20日，除权（息）日和现金红利发放日均为2025年10月21日。本次分红以公司总股本400,000,000股扣减回购专用账户股份2,713,876股后的397,286,124股为基数，合计派发现金红利39,728,612.40元，占2025年半年度归母净利润的27.99%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101300025446.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688161","BK0251"],"gpt_icon":0},{"id":"2565854341","title":"每周股票复盘：威高骨科（688161）拟取消监事会并修订章程","url":"https://stock-news.laohu8.com/highlight/detail?id=2565854341","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565854341?lang=zh_cn&edition=full","pubTime":"2025-09-07 05:24","pubTimestamp":1757193859,"startTime":"0","endTime":"0","summary":"截至2025年9月5日收盘，威高骨科报收于31.45元，较上周的31.67元下跌0.69%。本周，威高骨科9月2日盘中最高价报32.97元。威高骨科当前最新总市值125.8亿元，在医疗器械板块市值排名27/126，在两市A股市值排名1496/5152。本周关注点公司公告汇总：威高骨科拟取消监事会，相关职权由董事会审计委员会行使。公司公告汇总山东威高骨科材料股份有限公司拟召开2025年第一次临时股东大会，审议关于取消监事会、修订《公司章程》及修订公司部分管理制度的议案。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090700001036.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688161"],"gpt_icon":0},{"id":"2563359268","title":"每周股票复盘：威高骨科（688161）Q2净利增54.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2563359268","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2563359268?lang=zh_cn&edition=full","pubTime":"2025-08-31 09:20","pubTimestamp":1756603221,"startTime":"0","endTime":"0","summary":"截至2025年8月29日收盘，威高骨科报收于31.67元，较上周的31.37元上涨0.96%。本周，威高骨科8月26日盘中最高价报33.88元，股价触及近一年最高点。威高骨科当前最新总市值126.68亿元，在医疗器械板块市值排名27/126，在两市A股市值排名1507/5152。本周关注点业绩披露要点：2025年第二季度归母净利润9016.8万元，同比上升54.86%。股本股东变化截至2025年6月30日，公司股东户数为9034.0户，较3月31日增加130.0户，增幅1.46%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025083100002809.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688161"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1768155034319,"stockEarnings":[{"period":"1week","weight":0.0792},{"period":"1month","weight":0.0617},{"period":"3month","weight":-0.0588},{"period":"6month","weight":0.1469},{"period":"1year","weight":0.2905},{"period":"ytd","weight":0.0792}],"compareEarnings":[{"period":"1week","weight":0.0382},{"period":"1month","weight":0.0564},{"period":"3month","weight":0.0573},{"period":"6month","weight":0.1739},{"period":"1year","weight":0.2831},{"period":"ytd","weight":0.0382}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"山东威高骨科材料股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"10690人(较上一季度增加18.33%)","perCapita":"37418股","listingDate":"2021-06-30","address":"山东省威海市环翠区旅游度假区香江街26号","registeredCapital":"40000万元","survey":" 山东威高骨科材料股份有限公司的主营业务是骨科医疗器械的研发,生产和销售。公司的主要产品是骨修复材料、组织修复以及骨科手术器械等。","listedPrice":36.22},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"威高骨科(688161)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供威高骨科(688161)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"威高骨科,688161,威高骨科股票,威高骨科股票老虎,威高骨科股票老虎国际,威高骨科行情,威高骨科股票行情,威高骨科股价,威高骨科股市,威高骨科股票价格,威高骨科股票交易,威高骨科股票购买,威高骨科股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"威高骨科(688161)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供威高骨科(688161)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}